Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: biotechnology law
Federal Circuit Knocks Outside the Box’s Inequitable Conduct Charges Out of the Box
The following is a guest post from Schwegman Lundberg & Woessner’s associate Ricardo Moran. The issues on appeal were whether Travel Caddy, Inc. had committed inequitable conduct for: (i) not disclosing the existence of the litigation on U.S. Patent No. … Continue reading
Akami/McKesson Decision Re-defines Induced Infringement
In a 6-5 decision, the Fed. Cir., sitting en banc, decided two appeals which presented questions closely related to when an actor is liable for inducing infringement under 271(b); Akami Technologies, Inc. v. Limelight Networks, Inc. and McKesson Tech’s., Inc. … Continue reading
Appellate Court Ruling Permits Continued NIH Funding of Embryonic Stem Cell Research
On August 24th, the D.C. Cir. ruling dismissing the suit brought to block any federal funding of embryonic stem cell research was affirmed. Stem cell researchers can breathe a bit more easily, and keep the lights on in their labs … Continue reading
Posted in Stem Cells/Cloning
Tagged biotechnology law, stem cell research, Warren Woessner
Leave a comment
Admissibility of Disclaimers – New Lessons From The EPO Technical Boards of Appeal
The following is a guest post from the 8/12 newsletter of Dr. Stefan Danner of DHS Patentanwaltsgesellschaft mbH. Last year, the EPO Enlarged Board of Appeal (EBA) handed down its decision in case G2/10 relating to the admissibility of disclaimers whose … Continue reading